Ironwood Pharmaceuticals | IRWD - Assets



Ironwood Pharmaceuticals reported $351.3M in Assets for its fiscal quarter ending in December of 2024.


Assets Change Date
Acadia Pharmaceuticals USD 1.23B 93.19M Jun/2025
Agios Pharmaceuticals USD 1.47B 84.28M Jun/2025
Almirall EUR 2.31B 88.18M Jun/2025
Alnylam Pharmaceuticals USD 4.57B 352.21M Jun/2025
Amarin USD 655.68M 29.67M Mar/2025
Ardelyx USD 466.77M 31.02M Jun/2025
Astellas Pharma JPY 3.34T 3.71B Jun/2025
AstraZeneca USD 112.42B 6.17B Jun/2025
Charles River Laboratories USD 7.56B 21.82M Jun/2025
Exact Sciences USD 5.8B 86.29M Jun/2025
Halozyme Therapeutics USD 2.05B 142.63M Jun/2025
Incyte USD 5.82B 71.99M Jun/2025
Ironwood Pharmaceuticals USD 351.3M 38.22M Dec/2024
MacroGenics USD 245.42M 16.24M Jun/2025
Moderna USD 12.01B 694M Jun/2025
Myriad Genetics USD 1.01B 21.5M Mar/2025
Pacira USD 1.54B 49.41M Jun/2025
PTC Therapeutics USD 2.63B 21.23M Jun/2025
Sarepta Therapeutics USD 3.68B 214.43M Jun/2025
Takeda JPY 14T 243.81B Jun/2025
Ultragenyx Pharmaceutical USD 1.31B 5.66M Jun/2025